You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Médicaments

La bibliothèque de médicaments donne accès à des renseignements sur plus de 100 médicaments anticancéreux commercialisés au Canada.

Trouvez plus d’information sur la sécurité  dans le document patient supplémentaire Comment prendre vos médicaments oraux contre le cancer de manière sécuritaire.

Displaying Drugs List

13 Items
Other Name(s): Arimidex® (multiple brands available)
Funding:
ODB Limited Use
  • anastrozole - For the treatment of metastatic breast cancer in hormone receptor positive post-menopausal women
  • anastrozole - An alternative to tamoxifen for the adjuvant treatment of postmenopausal women with hormone receptor positive breast cancer
Apr 2016
Other Name(s): Trisenox® (Lundbeck)
Funding:
New Drug Funding Program
  • Arsenic Trioxide - First Line Consolidation of Acute Promyelocytic Leukemia (APL)
  • Arsenic Trioxide - First Line Induction of Acute Promyelocytic Leukemia (APL)
  • Arsenic Trioxide - Relapsed_Refractory Induction of Acute Promyelocytic Leukemia (APL)
  • Arsenic Trioxide - Relapsed_Refractory Consolidation of Acute Promyelocytic Leukemia (APL)
Apr 2016
Other Name(s): Leustatin® (generic brand available)
Apr 2016
Other Name(s): Zinecard® (Pfizer)
Apr 2016
Other Name(s): Zoladex® (AstraZeneca); Zoladex® LA (AstraZeneca)
Funding:
ODB - General Benefit
  • goserelin
Mar 2016
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Other Name(s): Intron A® (Merck)
Funding:
New Drug Funding Program
  • Interferon - Melanoma
ODB Limited Use
  • interferon alfa-2b - For hairy cell leukemia and Kaposi's Sarcoma
Aug 2016
Other Name(s): Lupron® (AbbVie); Lupron Depot® (AbbVie); Eligard® (Sanofi Aventis)
Funding:
ODB - General Benefit
  • leuprolide - long-acting formulation
Aug 2016
Other Name(s): Megace® (multiple brands available)
Funding:
ODB - General Benefit
  • megestrol - oral tablets
Aug 2016
Other Name(s): Atriance® (Novartis)
Apr 2016
Other Name(s): Sandostatin® (multiple brands available); Sandostatin® LAR™ (Novartis)
Funding:
ODB - General Benefit
  • octreotide
Aug 2016
Other Name(s): Zanosar® (Paladin Labs)
Aug 2016